Cardiac Insight has been cleared by the FDA to market Stealth, a wearable heart-monitoring device that can detect atrial fibrillation by interpreting ECG patterns using a patented algorithm. The Bellevue, Wash.-based startup said it costs less than $20 per unit to manufacture the lightweight device.

Full Story:

Related Summaries